Application of Transition-Metal Catalysis, Biocatalysis, and Flow Chemistry as State-of-the-Art Technologies in the Synthesis of LCZ696-Reference-Cited by-同舟云学术

Application of Transition-Metal Catalysis, Biocatalysis, and Flow Chemistry as State-of-the-Art Technologies in the Synthesis of LCZ696

Published:2020-05-15 Issue:11 Volume:85 Page:6844-6853
ISSN:0022-3263
Container-title:The Journal of Organic Chemistry
language:en
Short-container-title:J. Org. Chem.

Author:

Gu Xingxian¹,Zhao Jibin¹,Chen Like¹,Li Yunzhong¹,Yu Bo¹,Tian Xiangguang¹,Min Zhongcheng¹,Xu Su¹,Gu Huijuan¹,Sun Junjie¹,Lu Xiaoquan¹,Chang Meng¹,Wang Xufan¹,Zhao Liqun¹,Ye Shengqing¹,Yang Hongwei¹^ORCID,Tian Yingtao¹,Gao Feng¹,Gai Yu¹,Jia Guanghua²,Wu Jingjing²,Wang Yan²,Zhang Jianghua²,Zhang Xuesong²,Liu Weichun²,Gu Xin²,Luo Xi²,Dong Hai²,Wang Huaimin²,Schenkel Berthold³,Venturoni Francesco³,Filipponi Paolo³^ORCID,Guelat Bertrand³^ORCID,Allmendinger Thomas³,Wietfeld Bernhard³,Hoehn Pascale³,Kovacic Nikola³,Hermann Luca³,Schlama Thierry³,Ruch Thomas³,Derrien Nadine⁴,Piechon Philippe⁵,Kleinbeck Florian³^ORCID

Affiliation:

1. Suzhou Novartis Technical Development Co., Ltd., #18-1 Tonglian Road, Bixi Subdistrict, Changshu City, Jiangsu Province 215537, P.R. China

2. Novartis Pharmaceuticals (China) Suzhou Operations, Riverside Industrial Park Changshu Economic Development Zone, #18 Tonglian Road, Changshu, Jiangsu Province 215537, P.R. China

3. Chemical & Analytical Development, Novartis Pharma AG, 4056 Basel, Switzerland

4. Pharmaceutical & Analytical Development, Novartis Pharma AG, 4056 Basel, Switzerland

5. Novartis Institutes for Biomedical Research, Novartis Pharma AG, 4056 Basel, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.joc.0c00473

Reference37 articles.

1. Heart failure and the aging population: an increasing burden in the 21st century?

2. Long-term survival of cancer patients compared to heart failure and stroke: A systematic review